flurbiprofen has been researched along with MS (Multiple Sclerosis) in 4 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Consequently, the development of an easy-to-swallow liquid oral dosage form supported by a combined PBPK-IVIVC model was approached." | 1.51 | Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001. ( Ashtikar, M; Geisslinger, G; Jung, F; Nothnagel, L; Parnham, MJ; Rossmanith, T; Thurn, M; Wacker, MG, 2019) |
| "R-flurbiprofen treatment increased CD4(+)CD25(+)FoxP3(+) regulatory T cells, CTLA4(+) inhibitory T cells and interleukin-10, whereas the EAE-evoked upregulation of pro-inflammatory genes in the spinal cord was strongly reduced." | 1.40 | R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice. ( Altmann, C; Bishay, P; de Bruin, N; Ferreirós, N; Geisslinger, G; Häussler, A; Lötsch, J; Männich, J; Parnham, MJ; Schmitz, K; Tegeder, I; Ultsch, A, 2014) |
| "Flurbiprofen axetil was used for slight postoperative fever." | 1.35 | [Perioperative anesthetic management of a patient with multiple sclerosis]. ( Hirose, M; Ishimoto, M; Matsuki, Y; Nobukawa, Y; Okada, A; Shigemi, K; Shimizu, K; Tabata, M; Tsugita, K; Ueda, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, F | 2 |
| Thurn, M | 2 |
| Krollik, K | 1 |
| Li, D | 1 |
| Dressman, J | 1 |
| Alig, E | 1 |
| Fink, L | 1 |
| Schmidt, MU | 1 |
| Wacker, MG | 2 |
| Nothnagel, L | 1 |
| Rossmanith, T | 1 |
| Ashtikar, M | 1 |
| Geisslinger, G | 2 |
| Parnham, MJ | 2 |
| Schmitz, K | 1 |
| de Bruin, N | 1 |
| Bishay, P | 1 |
| Männich, J | 1 |
| Häussler, A | 1 |
| Altmann, C | 1 |
| Ferreirós, N | 1 |
| Lötsch, J | 1 |
| Ultsch, A | 1 |
| Tegeder, I | 1 |
| Okada, A | 1 |
| Hirose, M | 1 |
| Shimizu, K | 1 |
| Tsugita, K | 1 |
| Matsuki, Y | 1 |
| Nobukawa, Y | 1 |
| Tabata, M | 1 |
| Ishimoto, M | 1 |
| Ueda, M | 1 |
| Shigemi, K | 1 |
4 other studies available for flurbiprofen and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Sustained-release hot melt extrudates of the weak acid TMP-001: A case study using PBB modelling.
Topics: Administration, Oral; Arginine; Biological Availability; Delayed-Action Preparations; Drug Compoundi | 2021 |
Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001.
Topics: Administration, Oral; Anti-Inflammatory Agents; Computer Simulation; Deglutition; Deglutition Disord | 2019 |
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Encephalomyelitis, | 2014 |
[Perioperative anesthetic management of a patient with multiple sclerosis].
Topics: Adult; Anesthesia, Epidural; Fentanyl; Fever; Flurbiprofen; Humans; Infusions, Intravenous; Laparosc | 2009 |